INTRODUCTION
The immunological determinants expressed by the structural proteins of type C RNA viruses have been the object of intensive study. Murine virion structural proteins, p3o, gp7o and virus reverse transcriptase have been shown to possess type-specific antigenic able by electron microscopy and reverse transcriptase measurements 0oo to 2oo pmol/IO 6 cells; Sarma & Log, 3973; Sarma et al. 1975; O'Brien & Boone, 3977) .
Antisera used
Bovine anti-feline sarcoma virus (FeSV) . Bovine anti-FeSV was prepared by infecting a portion of thymic tissue from a young steer with FeSV (ST strain) and inoculating the cells back into the donor. The serum was a gift from Dr T. Kawakami.
Goat anti-FeLV-p27. Goat anti-p27 was prepared by immunizing goats with FeLV-p27 purified by isoelectric focusing. These sera were kindly provided by Drs R. Gilden and S. Oroszlan of Flow Laboratories, Inc. (Oroszlan et al. 3970; Oroszlan, Huebner & Gilden, ~973) .
Rat anti-murine sarcoma virus (MSV). Rat anti-MSV was obtained from Fischer rats bearing Moloney sarcoma virus induced tumours.
Goat anti-MuLV. Goat anti-MuLV was prepared by immunizing a goat with tweenether disrupted Moloney MuLV which had been banded by sucrose density gradient centrifugation.
Goat anti-Rauscher leukaemia virus (RLV)-p3o. Goat anti-RLV-p3o was prepared by immunizing goats with Rauscher MuLV-p3o purified by gel filtration in 6 M-guanidine hydrochloride.
Goat anti-RLV-gp7o. Goat anti-RLV-gp7o was prepared by immunizing goats with Rauscher MuLV-gp7o purified by gel filtration in 6 ~-guanidine hydrochloride.
Each of the antisera against murine viruses and their proteins were kindly provided by Dr Roger Wilsnack of Huntingdon Research Laboratories. IgG fractions from each serum were prepared by precipitation with 33 % ammonium sulphate. Two of the IgG preparations (anti-RLV-p3o and rat anti-MSV) were further purified by passage through Sephadex G35o. Binding data obtained with chromatographed IgG were indistinguishable from those obtained with crude ammonium sulphate fractions of the same antisera. Virus proteins (MuLV-p3o and gp7o) gave single bands on acrylamide gels and did not cross react in competition radio-immune assays.
Paired label assay for cell surface antigens. Cell surface antigens were quantitatively measured by the paired label assay (Boone, Irving & Rubinstein, 3973 ; Boone, Gordin & Kawakami, I973; O'Brien et al. 3976b) . Immune and normal IgG from the same animal species were purified and labelled catalytically with lsxI and 135I, respectively. A paired label mixture (PLM) consisting of equimolar amounts of normal and immune IgG was absorbed with xo ~ cultured mosquito cells/rag of IgG for 2 h at room temperature to remove nonspecific serum binding proteins, and with virus negative cat (CRFK) or mouse (Basc-2) cells to remove species-specific antigens. Target cells were incubated in I ml of an appropriate PLM for 3o min at 25 °C. The cells were washed three times and counted in dual channels in a gamma spectrometer. Using previously determined specific radioactivities (ct/min/mg protein), the amount (ng) of antibody binding per cell was determined as the difference between immune and normal IgG binding. Normal bovine, goat and rat sera were purchased from Grand Island Biological Company (Grand Island, New York) and tested for reactivity to type C virus proteins before use. The use of labelled normal IgG in the reaction mixture provides an internal control for the specificity of antibody binding.
Radioisotopic foot pad assay. The detection of cell mediated immunity was measured using a radioisotopic foot pad assay (Paranjpe & Boone, 3972; Davis & Boone, 3974) . The procedure involves the simultaneous inoculation of antigen in the mouse foot pad and 125I-labelled serum albumin into the peritoneal space. A positive immune reaction results in accumulation of circulating 125I-labelled serum albumin in the inflamed spaces in the inoculated foot. Control levels of radioactivity are obtained in the untreated contralateral foot pad. MSV(M) was obtained from tumour extracts of BALB/c mice containing a mixture of Moloney sarcoma virus and leukaemia virus. MSV(M) was provided by the virus cancer program of the National Cancer Institute. Immune and normal mice were inoculated with test cells (antigen) in the foot pad. Immediately thereafter, 125I-labelled human serum albumin was injected intraperitoneally. Twenty-four hours later the inoculated foot pad and the untreated contralateral control foot pad were cut off and counted in a gamma spectrometer. Results were expressed as the 'foot count ratio': ct/min of test foot divided by ct/min of control foot. Specificity of this assay for cellular immunity has been demonstrated previously (Paranjpe & Boone, I972; Davis & Boone, I975) .
Studies on tumour immunity. Male A/J mice were inoculated with 5 x ro 6 irradiated YAC, FL-74 or CRFK cells weekly for 3 weeks. Nine days following the last immunization, the mice were challenged with 5 x iO viable YAC cells subcutaneously. Twenty days later tumour incidence was determined. The tumours were then surgically removed and their weight determined.
BALB/c mice were immunized intraperitoneally three times at weekly intervals with Io 6 mitomycin C (zo/~g/ml)-treated MSC, FL-74 or CRFK cells. Two weeks after final immunization, animals were injected with io ~ f.f.u of MSV in the hind leg. Animals were observed twice weekly and tumour incidence determined.
RESULTS

Detection of MuLV and FeLV associated cell surface antigens by the paired label radio-assay
A group of six antisera (described in Methods) were selected for quantitative measurement of the expression of virus structural proteins and virus induced antigens of the cell surface of murine cells infected with MuLV and feline cells infected with FeLV. Three of the sera, bovine anti-FeSV, rat anti-MSV, and goat anti-MuLV were broadly reactive. The three component specific sera were selected from a number of lots of serum preparations on the basis of high titre and lack of specificities to virus proteins other than the indicated component (see below).
The number of antigenic determinants detected by each antiserum on a tested cell was determined from the results of an immune serum titration of a constant cell number in a fixed volume (Fig. I a, b) . Since antibody binding to cell surface antigens conforms to the mass action law, a linear equation was derived which permitted the determination of the maximum amount of antibody molecules which bound per million cells (termed ~ value) (Boone et al. I97I ; O'Brien et al. I976b) . By plotting the ng immune IgG bound versus the ng antibody bound//~g IgG/ml, the maximum binding capacity of Io 6 cells can be estimated from the extrapolated intercept of the line (Fig. I b) .
Immune serum titrations were performed using the six tested antisera on murine YAC, RAG and Basc-2 control cells and on feline FL-74 and CRFK control cells, fl values and antibody binding/Io 6 cells for each of the test systems are tabulated in Table I . The broadly reacting anti-MuLV sera bound to YAC cells in high amounts (325 ng/Io 6 cells), as did the monospecific goat anti-gp7o (77 ng/Io6 cells), whereas only small amounts of bound anti-RLV-p3o (I4 ng/lo 6 cells) were detectable. The broadly reacting bovine anti-FeSV and the anti-FeLV-p27 also bound to FL-74 cells in high concentrations, 400 and I4 ° ng/Io 6 cells respectively. None of the sera reacted significantly with the virus negative control cell lines. 
* Determined from immune serum titrations as illustrated in Fig. I (a, b) . fl values are expressed in ng/to 6 ceils. Numbers in parentheses are number of IgG molecules bound per cell × io -5. Values are averages of two to five titrations.
t Control values of o-o represent experimental situations where the 125I-labelled non-immune serum has a slightly greater affinity for the target cell than does the 13q-labelled antiserum. This variation is non-specific and varies with the cell and the serum. This variation also occurs in favour of the antiserum. Since the maximum deviation in the control cell below o was approximately -2 ng, we arbitrarily discount any binding below 2 ng as being specific.
:~ This value represents a minimum value since the titration remained in extreme antigen excess. * Cell titrations were carried out at an immune IgG concentration of 5o #g/ml as described in Methods. Values are averages of two to six titrations. Each result was determined as illustrated in Fig. I The above data were verified using cell titration studies (Fig. I c) . In these experiments, immune IgG protein concentration (50/zg/ml) of each of the six antisera was held constant while cell concentrations were varied. The initial slope of a plot of ng IgG bound v. cell concentration provides an estimate of the maximum IgG bound/Io 6 cells at the stated immune serum concentration (O'Brien et al. I976a, b) . The number obtained by this plot may be lower than the/~ value obtained from immune serum titrations by a constant factor that depends on the antibody concentration and the equilibrium constant of the reaction between surface sites and antibodies. Since the antibodies tested may be multivalent and therefore elicit multiple antibody specificities, the results of cell titrations (Table 2) are best interpreted as sensitive qualitative estimates of antigen expression. In addition to confirming the conclusions derived from Table ~, the cell titration experiments detected strong interspecies p3o determinants on the murine RAG and A-9 cell surfaces. The detection of interspecies determinants of FeLV-p27 on FL-74 cells is evident from the immune serum titration (Table I) , although the cell titration was not sensitive enough to reveal them.
The cell titrations with the goat anti-RLV-gp7o revealed significant reactivity on virus infected feline and murine cells. Only RAG cells failed to bind anti-gp7o despite the higher * Immune IgG (2 5 ]tg) in a paired label mix was incubated with increasing amounts of the absorbing virus component (up to Io #g p3o, pz7 or gP7o) in o'7 ml PBS at 4 °C. After 4 h, o'I ml foetal bovine serum and 2 × Io 7 target cells were added to the mixture and tested for cell membrane binding as described in Methods. Values are plateau levels of maximum absorption.
~ Purified FeLV was obtained from high speed pellets of filtered (MiIlipore o'45/zm) culture fluid from 23 h log phase FL-74 cultures. Virus pellets from 3 x To 8 FL-74 cells were suspended in o'7 ml PBS to which was added o'2 ml of anti-FeSV PLM.
:~ These values were the lowest observed but the absorption curves were still declining at the maximum concentration of absorbent. levels of p3o detected on this same cell (Table 2 ). Since the anti-gp7o sera bound both virus infected mouse cells and FL-74 cells, the RAG cell must lack both group and interspecies gp7o determinants on their cell surface. The possibility that group-specific region(s) of cell membrane bound gp7o were relatively inaccessible has been suggested (Obata et al. i975; Tung et al. I975 )-The binding of anti-gp7o to A-9 ceils in this study suggested that the A-9 virus contains gP7o determinants that are antigenicaIly related to RLV-type gp7o. Immunological relatedness between the A-9 virus and Moloney virus has been demonstrated by immunofluorescence with anti-Moloney leukaemia virus (Fenyo, Nordenskjold & Klein, I97I ; Fenyo et al. ~973) . In the absence of type-specific antisera for the RAG and A-9 virus glycoproteins, we can only state that both YAC and A-9 cells express a gp7o antigen on their cell membranes which is detectable by anti-RLV-gp7o. This antigen is either absent or inaccessible to antibody on the RAG cell surface.
Specificity of MuLV and FeLV antisera
Specificity of the test antisera was demonstrated by a quantitative absorption of various labelled antisera with purified structural protein, with intact virus particles, or with disrupted virions prior to the exposure of the PLM to a positive target cell (Table 3 ). The monospecific antisera were absorbed with proteins prepared by a procedure (isoelectric focusing or gel filtration) different from the procedure used to purify the immunogen used in serum preparation.
Absorption of the respective mono-specific antisera with FeLV-p27 and RLV-p3o caused a large reduction in cell surface binding. There was no reduction of binding of the p3o antiserum by pre-absorption to gp7o or vice-versa (anti-gp7o absorbed with p3o). s.j. O'BRIEN, J. M. SIMONSON AND S. DAVIS The absorption of anti-gp7o with purified gp7 o resulted in an enhancement of anti-gp7o binding to MuLV infected cells. This finding may be due either to the fact that the gp7o is polyvalent and formed aggregates with antibodies that bound to the cell surface through bivalent antibody linkages, or that some of the purified gp7o became bound to available surface receptors for virus attachment (DeLarco & Todaro, I976). If gp7o antigenic determinants remain accessible to antibody binding when the glycoprotein is bound to cellular receptors, then an enhancement of antibody binding would be observed. Passive absorption experiments with MuLV-gp7o on virus negative cells in our laboratory (S. J. O'Brien, unpublished observations) and elsewhere (DeLarco & Todaro, I976) have demonstrated the binding of considerable quantities of antigenically active gp7o on cell surfaces. Two other virus producing cells, A-9 and LSTRA, also exhibit this effect to an even greater extent with purified gp7o and anti-gp7o IgG but not with other absorbants (Table 3 )-The effect was specific for gp7o since serum proteins or RLV-p3o result in no increase in binding of anti-gp7o IgG.
The bovine FeLV antiserum was only partially reduced in its binding to FL-74 cell surfaces by absorption to FeLV-p27. Absorption of this same antiserum with sonicated FeLV particles completely abolished binding to FL-74 cell surfaces suggesting that the majority of residual antibodies are specific for virion proteins. We cannot, however, exclude any non-virion antigens which might have co-purified in membrane vesicles with FeLV. The MSV antiserum contained no detectable p3o specificities since absorption with purified MuLV-p3o failed to reduce binding to YAC or FL-74 ceils.
Antibody blocking experiments as a measure of shared specificities and topographical association of virus antigens
Cells were incubated for 6o rain with increasing quantities of an unlabelled antiserum, washed and tested for binding using a PLM of a second antiserum (Table 4 )-The gp7o and the p3o antisera were effective in blocking themselves but did not reduce each other's binding to MuLV infected YAC cells. The FeSV antiserum was blocked partially by antiFeLV-p27, again consistent with the presence of multiple specificities in the FeSV antisera including anti-p27. Binding of the MSV serum to YAC and FL-74 cells was reduced by binding of FeSV serum but not by either the anti-p3o or anti-gp7o sera, suggesting that the majority of specificities of the MSV sera were neither p3o or gp7o specific. The reciprocal experiment, however, revealed that unlabelled MSV serum did partially reduce the binding of labelled anti-p3o and anti-gp7o to YAC ceils. This block may reflect proximity of the cell surface p3o and gp7o antigens to a third MSV antigen. When two antigens of different specificities are located in close proximity on the cell surface, the binding of antibody to one can impede the subsequent absorption of antibody by the other (Boyse, Old & Stockert, I968) . This explanation is supported by the paucity of p3o specificities found in the MSV antiserum (Table 3) .
Presence of virus antigens in addition to p3o and gp7o on infected cell surfaces
The immune serum titrations, absorption experiments, and antibody competition experiments with the broad specificity antisera suggest that additional virus structural components are also expressed on infected cell surfaces. The maximum binding of anti-FeSV to FL-74 cells in this study was I-6 x io 6 binding sites. This estimation represents twice the number of p3o plus gp7o determinants calculated to be on FL-74 cells using the same methodology (Table I) . Similarly, rat anti-MSV serum detected 5.2 × Io ~ determinants per YAC cell, very little of which is detected by the p3o or gp7o sera (Table I, * Cells (5 × IO6) were incubated in 0-7 ml PBS containing increasing amounts (up to I "4 rag) of unlabelled blocking IgG for 60 min at 25 °C. At the end of the incubation period o'I ml of heat inactivated bovine serum and o-2 ml of a PLM mix (2o t~g immune IgG) were added to each tube. After 3o rain incubation the cells were washed and counted. The #g IgG bound were plotted v. #g unlabelled blocking serum and the maximum reduction in unblocked IgG binding was determined.
Interspecies cross reaction of MS V antigen(s) which induced cell mediated immune response
The ability of interspecies cross reacting virus associated cell membrane antigens to elicit a cellular immune response in vivo was examined by the radioisotopic foot pad assay.
BALB/c mice were injected with MSV. Tumour bearing mice were selected as immune target animals at I4 to I6 days following infection, a time empirically determined to be the optimum for MSV cellular immunity. MSV immune mice were challenged in the foot pad with Io 6 YAC, FL-74 , and CRFK cells (Table 5) . By this assay no significant cell mediated immune reaction was detected when FeLV infected cat cells and the virus negative CRFK cells were used as antigens. Murine virus infected YAC cells elicited a significant positive reaction.
Tumour associated transplantation antigens
The ability of cat cells infected with FeLV to serve as immunogens against tumour producing doses of Moloney sarcoma virus was examined with a tumorigenicity monitor (Fig. 2) . Immunization of BALB/c mice with syngeneic MSC cells infected with MSV was absolutely protective against MSV challenge, but three immunizations of lO 6 FL-74 cells, like virus negative feline cells, failed to protect the mice from MSV derived tumours.
A second experimental approach to detect interspecies virus associated tumour protection was performed using YAC and FL-74 ceils as immunogens while challenging with YAC cells (Table 6 ). The YAC cell expresses a weak tumour transplantation antigen (Fenyo et al. I970 , which is not effective in preventing tumour growth induced by YAC cells.
Immune reaction is, however, reflected in diminution of tumour size by weight (Table 6 ). The xenogeneic immunization with FL-74 cells failed to reveal any protective interspecies antigens between FeLV and MuLV since the mice immunized with FL-74 cells produced tumours of the same size as the control mice which had been immunized with normal cat cells or saline. * Male strain A/J mice were inoculated three times with X-irradiated cells at 7 day intervals. Nine days after the third immunization, the mice were challenged with 5 × Io4 viable YAC tumour cells injected subcutaneously.
"i" Twenty-eight days following challenge, the turnouts were surgically dissected and their weight was determined. $ Student's t-test of mean turnout weights; NS = not significant when compared to non-immune control. 
DISCUSSION
This study illustrates that a number of immunologically detectable virion components are expressed on murine and feline cell membranes of type C-virus producing cells. Antigens found on both the major internal structural protein p27-3o and the virus envelope glycoprotein gp7 o are found in large amounts on MuLV and FeLV infected cells. Interspecies and intraspecies determinants of these two proteins are detectable by both monospecific and broadly reactive antisera. These results are in agreement with several reports (Yoshiki, Mellors & Hardy, I973; Grant et al. 1974; Yoshiki et al. 1974; O'Brien et al. 1976a ) of p3o on cell surfaces of virus producer and non-producer cells of mice and man.
In several recent reports (Oskarsson et al. I975; Tung, Yoshiki & Fleissner, 1976; Ledbetter, Nowinski & Emery, 1977 ) the presence of p3o on MuLV producing cells has been associated with large gag gene polyproteins of mol. wt. 85o0o and 95ooo, designated gp85 gag and gp95 gag. The polyproteins contain not only p3o determinants but also plo and pi2 determinants in the case of gp95 gag while gpa5gag has only p3o and pt2. The polyproteins are glycosylated, and do not chase into the virion particles. It is possible that the cell surface p3o specificities reported in these studies may also reside on unprocessed gag region polyproteins. In light of the finding of correlative appearance of leukaemia and gp85gag/gp95 gag on pre-leukaemia AKR thymocytes (Tung et al. 1976) , the fluctuating p3o levels observed in the various lines studied here may reflect different stages of leukaemic potential as well as virogene expression.
The finding of gp7o on virus producing cells is predicted since this glycoprotein is the major surface component of budding virions. This glycoprotein is also found on the cell surface of a number of non-virus producing normal mouse tissues (Lerner et al. 1976 ) and has been identified as the carrier of the G1x type-specific cell surface antigen on G~x + mouse thymocyte cell surfaces (Obata et al. 1975; Tung et al. 1975) .
The amounts of both p3o and gp7 o detected on various cell types varied considerably from cell to cell and did not correlate with any other virus antigen or virus production itself. These variations may reflect different levels of passive absorption, divergent cell surface architecture or different turnover of virus antigenic components in various cell types.
A number of additional virion structural proteins have been detected on surfaces of retrovirus infected cells in our laboratory and elsewhere. These include the smaller gag region proteins pro, pI2 and p15 and the lower tool. wt. envelope glycoprotein pI5e (Grant et al. I974; Fenyo & Klein, 1976; Lerner et al. I976; Tung et al. 1976; W. H. Jarrett, personal communication) . The feline oncornavirus cell membrane antigen (FOCMA) has also been detected on cell surfaces of feline lymphoid lines including FL-74 (Essex, 1975; Sliski et al. 1977 )-There is indirect evidence that FOCMA is host specified but virus induced, in an analogous manner to the avian TSSA induced by avian sarcoma virus (Kurth & Bauer, 1973 ; Essex, I975 ). An analogous antigen (MCSA) has been detected on YAC cell surfaces. MCSA does not cross react with any virus structural proteins and its presence on YAC cell surfaces is positively correlated with immunogenicity and tumour rejection sensitivity (Fenyo & Klein, I976) . The relative contribution of each of these virion and non-virion antigens to the total antigen deposition described here by the broad specificity antisera is presently under investigation.
The failure to detect cell mediated immunity against FeLV infected cells in MSV immune mice suggests that the interspecies determinants detected by antibody procedures on FL-74 
